TransMedics Group Inc (TMDX)
Days of sales outstanding (DSO)
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 4.45 | 4.42 | 3.62 | 3.80 | 3.16 | 3.18 | 3.08 | 3.38 | 3.26 | 3.96 | 3.33 | 5.10 | 6.80 | 4.77 | 3.40 | 3.74 | 3.92 | 5.46 | 4.31 | 3.60 | |
| DSO | days | 82.02 | 82.57 | 100.73 | 96.04 | 115.41 | 114.82 | 118.32 | 107.83 | 112.09 | 92.10 | 109.47 | 71.57 | 53.67 | 76.44 | 107.27 | 97.72 | 93.13 | 66.88 | 84.61 | 101.42 |
September 30, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 4.45
= 82.02
The days sales outstanding (DSO) for TransMedics Group Inc has fluctuated over the past few quarters. In the most recent quarter, September 30, 2024, the DSO was 82.02 days, which indicates that on average, it takes the company 82.02 days to collect its accounts receivable. This reflects an improvement compared to the previous quarter's DSO of 82.57 days. However, when compared to historical data, the DSO has varied significantly, with peaks recorded in March 31, 2023 (118.32 days) and September 30, 2023 (115.41 days).
Overall, the trend in DSO suggests that TransMedics Group Inc has experienced fluctuations in its accounts receivable collection efficiency over the past few quarters. It is essential for the company to manage its receivables effectively to ensure timely collection and maintain healthy cash flow levels.
Peer comparison
Sep 30, 2024